Zobrazeno 1 - 10
of 865
pro vyhledávání: '"F Portaels"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Médecine et Santé Tropicales. 23:450-457
Dans les annees soixante, les premiers cas d’ulcere de Buruli (UB) ont ete decrits au Gabon. Entre 2005 et 2011, des cas cliniquement suspects d’UB ont ete recherches dans les neuf provinces du Gabon et les lesions prelevees pour confirmation mic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::777ae7d7039c3379b0c33f7f055fe206
https://doi.org/10.1684/mst.2013.0259
https://doi.org/10.1684/mst.2013.0259
Publikováno v:
Revue medicale de Bruxelles. 36(6)
Democratic Republic of Congo (DRC), a particular form of juvenile delinquency and insecurity intensifies in the city of Kinshasa. This is the phenomenon Kuluna. It is organized gangs equipped with machetes and other weapons. The main objective of thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eb32d9af7a2d76d1b88bbeaf39854157
https://pubmed.ncbi.nlm.nih.gov/26837110
https://pubmed.ncbi.nlm.nih.gov/26837110
Publikováno v:
Clinical Microbiology and Infection. 13(8):754-762
Several new methods to detect drug resistance in Mycobacterium tuberculosis have been proposed in recent years. Colourimetric methods that use redox indicators or the nitrate reduction assay have received increasing attention because of their simplic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ca3f6e27519e0eb84494bd36503383d
Autor:
F Portaels, J C Palomino
Publikováno v:
European Journal of Clinical Microbiology and Infectious Diseases. 18:380-383
The aim of this study was to evaluate a simple method using a commercial colorimetric assay (Alamar Blue Oxidation-Reduction Indicator; Accumed, USA) in a microtiter format for testing the susceptibility of 94 strains of Mycobacterium tuberculosis to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d09b5b44aff098579c7855c65b1bb789
https://doi.org/10.1007/pl00015025
https://doi.org/10.1007/pl00015025
Autor:
I. Bastian, F. Portaels
Multidrug-resistant tuberculosis: past, present and future Ivan Bastian and Franyoise Portaels Mycobacteriology Unit. Institute of Tropical Medicine. Antwerp. Belgium The Lord hath created medicines out of the earth and he that is wise will not abhor
Autor:
Miriam Eddyani, F Portaels
Publikováno v:
Clinical Microbiology and Infection. 13(10):1033-1035
Bone infection and metastatic spread in cases of Buruli ulcer imply that Mycobacterium ulcerans is able to survive and multiply at 37°C. This study investigated the survival at 37°C of M. ulcerans isolates from diverse geographical and clinical sou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16a2fa7df1b2cc90b9c794f335febcfd
Autor:
F. Portaels, J. C. Palomino
Publikováno v:
Journal of Clinical Microbiology. 36:402-408
We used the BACTEC system to evaluate the effects of several decontamination methods and the addition of antibiotics on the viability of Mycobacterium ulcerans . The effects of polyoxyethylene stearate or egg yolk as supplements were also evaluated t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be5c7395e7cd445286f0922d969be30d
https://doi.org/10.1128/jcm.36.2.402-408.1998
https://doi.org/10.1128/jcm.36.2.402-408.1998
Publikováno v:
Bulletin of the World Health Organization, Vol 78, Iss 2, Pp 252-257
Multidrug-resistant tuberculosis (MDRTB) should be defined as tuberculosis with resistance to at least isoniazid and rifampicin because these drugs are the cornerstone of short-course chemotherapy, and combined isoniazid and rifampicin resistance req
Externí odkaz:
https://doaj.org/article/8cbc3332deb5432f8706e8e3b9497c9d
Autor:
C Abe, Max Salfinger, Diana L. Williams, K. D. Eisenach, C M Nolan, V. Sticht-Groh, Thomas P. Gillis, C Waguespack, Jack T. Crawford, F. Portaels
Publikováno v:
Antimicrobial Agents and Chemotherapy. 38:2380-2386
The emergence of rifampin-resistant strains of pathogenic mycobacteria has threatened the usefulness of this drug in treating mycobacterial diseases. Critical to the treatment of individuals infected with resistant strains is the rapid identification
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::253083ce5f45745570d7bc30cd630e2b
https://doi.org/10.1128/aac.38.10.2380
https://doi.org/10.1128/aac.38.10.2380